Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/key262
PubMed Identifier: 30137641
Publication URI: http://europepmc.org/abstract/MED/30137641
Type: Journal Article/Review
Volume: 58
Parent Publication: Rheumatology (Oxford, England)
Issue: 1
ISSN: 1462-0324